The Stryker Rejuvenate and ABG II are modular design hip replacement systems that utilize a titanium neck with a cobalt chromium (CoCr) stem. Unlike other defective metal-on-metal hip replacement systems, the Rejuvenate and ABG II do not contain metal-on-metal ball and socket components. However, because of the metal-on-metal modular-neck design, patients are still exposed to the risks associated with metal-on-metal articulation. Patients with the Rejuvenate or ABG II systems are reporting many of the same complications as patients with other metal-on-metal hip replacement systems. The Rejuvenate and ABG II systems were marketed as providing enhanced stability and flexibility by allowing surgeons to closely match the biomechanics of each patient and by reducing the risk of dislocations and costly revision surgeries.
The Rejuvenate system was approved by the U.S. Food and Drug Administration (FDA) in June 2008 through the 510(k) Premarket Notification Process. The ABG II system was approved under the same program in November 2009.
On July 6, 2012 Stryker voluntarily recalled its Rejuvenate and ABG II modular-neck stems because of complications due to fretting and corrosion at the modular-neck junction. Patients reported complications similar to those seen with other defective metal-on-metal hip replacements including:
- Swelling of the hip and groin
- Bone staining
- Nerve, muscle and tissue damage
- Hip, groin and leg pain
- Elevated metal ion levels in the bloodstream
There is ongoing litigation across the nation regarding the defective Stryker Rejuvenate and ABG II Hip Systems. If you underwent hip replacement surgery with the Stryker Rejuvenate System or ABG II Hip System, please contact our firm at 1-800-247-1623 or firstname.lastname@example.org for a free consultation to discuss your legal rights.
Click here to read the frequently asked questions regarding the Stryker Rejuvenate & ABG II Hip Systems Recall.
Click here to read the F.D.A.’s recall notice regarding the Stryker Rejuvenate & ABG II Hip Systems.